AU2003281862A1 - Stabilisation of nucleic acids - Google Patents

Stabilisation of nucleic acids

Info

Publication number
AU2003281862A1
AU2003281862A1 AU2003281862A AU2003281862A AU2003281862A1 AU 2003281862 A1 AU2003281862 A1 AU 2003281862A1 AU 2003281862 A AU2003281862 A AU 2003281862A AU 2003281862 A AU2003281862 A AU 2003281862A AU 2003281862 A1 AU2003281862 A1 AU 2003281862A1
Authority
AU
Australia
Prior art keywords
nucleic acid
stabilisation
nucleic acids
sample
protecting group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003281862A
Other languages
English (en)
Other versions
AU2003281862A8 (en
Inventor
Andrew Simon Goldsborough
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cyclops Genome Sciences Ltd
Original Assignee
Cyclops Genome Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyclops Genome Sciences Ltd filed Critical Cyclops Genome Sciences Ltd
Publication of AU2003281862A8 publication Critical patent/AU2003281862A8/xx
Publication of AU2003281862A1 publication Critical patent/AU2003281862A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003281862A 2002-08-02 2003-07-18 Stabilisation of nucleic acids Abandoned AU2003281862A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0217963.8 2002-08-02
GBGB0217963.8A GB0217963D0 (en) 2002-08-02 2002-08-02 Purification of nucleic acids
PCT/GB2003/003131 WO2004013155A2 (fr) 2002-08-02 2003-07-18 Stabilisation d'acides nucleiques

Publications (2)

Publication Number Publication Date
AU2003281862A8 AU2003281862A8 (en) 2004-02-23
AU2003281862A1 true AU2003281862A1 (en) 2004-02-23

Family

ID=9941619

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003281862A Abandoned AU2003281862A1 (en) 2002-08-02 2003-07-18 Stabilisation of nucleic acids

Country Status (7)

Country Link
US (1) US20060147918A1 (fr)
EP (1) EP1525309B1 (fr)
JP (1) JP2005538116A (fr)
AT (1) ATE554165T1 (fr)
AU (1) AU2003281862A1 (fr)
GB (1) GB0217963D0 (fr)
WO (1) WO2004013155A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60032235T2 (de) * 1999-04-30 2007-11-15 Cyclops Genome Sciences Ltd., West Kirby Ribonukleinsäurederivate
GB0317199D0 (en) 2003-07-23 2003-08-27 Cyclops Genome Sciences Ltd Clean-up beads
WO2005012522A1 (fr) * 2003-07-23 2005-02-10 Cyclops Genome Sciences Limited Billes decontaminantes
CN101124321B (zh) 2004-11-05 2012-02-29 恰根北美控股有限公司 用于从稳定剂中纯化核酸的组合物和方法
WO2006068935A1 (fr) * 2004-12-21 2006-06-29 Instrumentation Laboratory Company Resuspension de particules magnetisables
EP1996931B1 (fr) 2005-12-28 2013-11-27 The General Hospital Corporation Procedes et systemes de tri de globules sanguins
JPWO2007119717A1 (ja) * 2006-04-13 2009-08-27 大正製薬株式会社 アルドヘキソピラノース中間体の製造法
US20080146789A1 (en) * 2007-03-20 2008-06-19 Braman Jeffrey C Methods for the separation of biological molecules using dioxolane
JP2010523078A (ja) * 2007-03-30 2010-07-15 キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング リボース環を含む修飾ポリヌクレオチド
JP5221897B2 (ja) * 2007-05-22 2013-06-26 栄研化学株式会社 核酸回収試薬およびそれを用いた核酸増幅試薬キット、ならびに核酸回収方法およびそれを用いた核酸増幅方法
US20100076183A1 (en) * 2008-09-22 2010-03-25 Dellinger Douglas J Protected monomer and method of final deprotection for rna synthesis
US8420801B2 (en) 2010-01-08 2013-04-16 Roche Molecular Systems, Inc. Recovery of nucleic acids from magnetic glass particles
FR2968302B1 (fr) 2010-12-06 2012-11-30 Biomerieux Sa Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits
WO2013004710A2 (fr) * 2011-07-04 2013-01-10 Qiagen Gmbh Réactif pouvant être utilisé pour isoler et/ou purifier les acides nucléiques
DK2742152T3 (en) * 2011-08-12 2017-07-31 Qiagen Gmbh PROCEDURE FOR ISOLATING NUCLEIC ACIDS
US9040679B2 (en) 2012-04-30 2015-05-26 General Electric Company Methods and compositions for extraction and storage of nucleic acids
US9044738B2 (en) 2012-04-30 2015-06-02 General Electric Company Methods and compositions for extraction and storage of nucleic acids
US9040675B2 (en) 2012-04-30 2015-05-26 General Electric Company Formulations for nucleic acid stabilization on solid substrates
US9480966B2 (en) 2012-04-30 2016-11-01 General Electric Company Substrates and methods for collection, stabilization and elution of biomolecules
FR2994184B1 (fr) 2012-08-02 2017-12-08 Biomerieux Sa Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride aza-isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits
GB201303666D0 (en) * 2013-03-01 2013-04-17 Goldsborough Andrew S Sample fixation and stabilisation
EP3754011B1 (fr) 2015-09-09 2022-02-16 Drawbridge Health, Inc. Dispositifs pour la collecte, la stabilisation et la conservation d'échantillons
US20180135040A1 (en) 2016-02-16 2018-05-17 Life Magnetics, Inc. Methods for separating nucleic acids with graphene coated magnetic beads
US20170233719A1 (en) * 2016-02-16 2017-08-17 Life Magnetics, Inc. Methods for separating nucleic acids with graphene coated magnetic beads
FR3078977B1 (fr) * 2018-03-16 2023-03-17 Biomerieux Sa Procede d'extraction d'acides nucleiques

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3433649A1 (de) * 1984-09-13 1986-03-20 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Verfahren zur aufreinigung synthetischer oligonucleotide
US5804683A (en) * 1992-05-14 1998-09-08 Ribozyme Pharmaceuticals, Inc. Deprotection of RNA with alkylamine
WO1995006652A1 (fr) * 1993-08-30 1995-03-09 Promega Corporation Compositions et procede de purification d'acides nucleiques
US5959098A (en) * 1996-04-17 1999-09-28 Affymetrix, Inc. Substrate preparation process
EP0880536B2 (fr) * 1996-02-06 2015-08-05 Roche Diagnostics GmbH Procede pour la preparation d'acide nucleique purifie et utilisation de ce dernier
DE59912604D1 (de) * 1998-02-04 2005-11-03 Merck Patent Gmbh Verfahren zur isolierung und aufreinigung von nucleinsäuren
DE60032235T2 (de) * 1999-04-30 2007-11-15 Cyclops Genome Sciences Ltd., West Kirby Ribonukleinsäurederivate
JP2004523229A (ja) * 2001-01-16 2004-08-05 インヴィトロジェン コーポレーション Ｒｎａ単離のための試薬

Also Published As

Publication number Publication date
AU2003281862A8 (en) 2004-02-23
EP1525309B1 (fr) 2012-04-18
GB0217963D0 (en) 2002-09-11
JP2005538116A (ja) 2005-12-15
ATE554165T1 (de) 2012-05-15
WO2004013155A3 (fr) 2004-04-08
WO2004013155A2 (fr) 2004-02-12
US20060147918A1 (en) 2006-07-06
EP1525309A2 (fr) 2005-04-27

Similar Documents

Publication Publication Date Title
AU2003281862A1 (en) Stabilisation of nucleic acids
MXPA02006145A (es) Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina.
NO972268D0 (no) Fremgangsmåte og anlegg for behandling av avlöpsvann
AU2002325865A1 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced talb gene
WO2003008444A3 (fr) Peptides efficaces pour le traitement de tumeurs ou autres maladies necessitant l'ablation ou la destruction de cellules
WO2004029045A3 (fr) Procede de preparation d'inhibiteurs quinazoline de rho-kinase et leurs intermediaires
DE3889129D1 (de) Methode zum Modifizieren des Nebenproduktes eines Abgassbehandlungsprozesses.
ZA200108684B (en) Method of enhancing biological effectiveness of plant treatment compositions.
ATE467673T1 (de) Verfahren zur herstellung ätherischer öle durch behandlung mit superkritischem wasser sowie ätherische öle erhältlich durch behandlung mit superkritischem wasser
ATE202598T1 (de) Biologisches produkt zur physikalisch-chemischen weinstabilisierung
ATE368110T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
DE60040656D1 (de) Verfahren zur einführung von inhibitorischer rna in pflanzen und deren anwendungen
WO1988003927A3 (fr) Inhibiteurs de la renine
CA2306595A1 (fr) Methode de retention et d'augmentation en acide y-aminobutylique dans les feuilles d'herbes
ATE312800T1 (de) Verfahren zur behandlung von abwasser
HUP0003652A2 (hu) Eljárás növényi fehérjék kezelésére és ezekből készített élelmiszer-termékek
ATE370242T1 (de) Verfahren zur herstellung von dipeptiden
WO1997010366A3 (fr) Procede d'examen a haut rendement pour le depistage de sequences ou d'alterations genetiques dans des acides nucleiques
DE50213120D1 (de) Mikrobiologisches verfahren zur herstellung von amiden
DE69811893D1 (de) Verfahren zur herstellung von azetidin-2-carbonsäure und zwischenprodukten davon
WO2004046327A3 (fr) Oliogonucleotides inhibiteurs diriges sur bcl-2
EP1041057A3 (fr) Procédé de stérilisation de fumier de porc et d'élimination des composés nitrogénés par strippage d'ammonium
CY1109586T1 (el) Επεξεργασια λιγνοκυτταρινουχων υποστρωματων με οζον
DE69821483D1 (de) Verfahren zur gewinnung von chinaprylhydrochlorid und solvaten, die bei der isolierung und reinigung von chinaprylhydrochlorid nützlich sind
TH19693A (th) การบำบัดทางชีวภาพโดยเอนไซม์

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase